tofisopam has been researched along with papaverine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Bihel, FJ; Bourguignon, JJ; Hellal, M; Ibrahim, MA; Justiniano, H; Lugnier, C; Schmitt, M | 1 |
Efremov, LI; Firsova, LD; Ianova, OB; Kostiuchenko, LN; Pichugina, IM; Vasnev, OS | 1 |
3 other study(ies) available for tofisopam and papaverine
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam.
Topics: Benzodiazepines; Inhibitory Concentration 50; Papaverine; Phosphodiesterase 4 Inhibitors | 2011 |
[Nutricional support in the complex treatment of a patient with esophageal spasm].
Topics: Antidepressive Agents; Benzodiazepines; Combined Modality Therapy; Drug Therapy, Combination; Enteral Nutrition; Esophageal Spasm, Diffuse; Female; Humans; Middle Aged; Papaverine; Parasympatholytics; Treatment Outcome | 2013 |